Global Bladder Cancer Market
Bladder Cancer Market Size And Forecast
According to Verified Market Research, the Bladder Cancer Market was valued at USD 3.43 Billion in 2018 and is projected to reach USD 4.71 Billion by 2026, growing at a CAGR of 4.03% from 2019 to 2026.
Global Bladder Cancer Market Outlook
The factors such as an increasing incidence of bladder cancer, rise in awareness about cancer and their available therapies, increasing healthcare expenditure, growing smoking and tobacco consumption are expected to fuel the growth of the global bladder cancer market. Moreover, increasing focus of key players on different growth strategies such as research and developments activities, product approvals are further expected to boost the market. For instance, in February 2017, Bristol-Myers Squibb, a U.S.-based pharmaceutical company received the U.S. FDA approval for Opdivo injection, which is used for the treatment of urothelial carcinoma or bladder cancer. Furthermore, in August 2019, Roche Holding AG, announced positive result for Tecentriq, used for the treatment of bladder cancer. Nonetheless, rising number of drug patent expirations, high costs of therapies, increasing use of generic drugs, and unaffordable and inaccurate diagnosis are some factors that might impede the market growth.
Global Bladder Cancer Market Competitive Landscape
The Global Bladder Cancer Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as AstraZeneca plc, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi S.A., F. Hoffmann-La Roche AG, Novartis, Allergan Inc., Pfizer, GlaxoSmithKline, and AVI Biopharma Inc.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.